Core Viewpoint - The company, Hualv Biotechnology, has reported a significant increase in revenue projections for 2024, reaching 1.032 billion yuan, up from 578 million yuan in 2021, indicating strong growth in its product offerings and market expansion [1] Product Offerings - The main products of the company include enoki mushrooms, true shiitake mushrooms (which encompass varieties such as crab-flavored and white jade mushrooms), maitake mushrooms, cordyceps flowers, and deer antler mushrooms [1] - Cordyceps flowers and deer antler mushrooms are newly launched products post-IPO, showcasing the company's commitment to diversifying its product range [1] Revenue Growth - The projected revenue for 2024 is 1.032 billion yuan, which represents a notable increase compared to the 578 million yuan reported in 2021, highlighting the company's growth trajectory [1]
华绿生物：公司目前主要产品有金针菇、真姬菇等品类